mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
2e-05 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |